603182.SHG Shandong Sinoglory Health
- Market cap
- CNY 1.90B
- P/E
- 21.8x
- P/B
- 1.70x
- ROE
- 8.9%
- Dividend yield
- 3.48%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603182.SHG undervalued?
Graham number603182.SHG trades 28.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shandong Sinoglory Health fundamental analysis
No fundamental analysis for Shandong Sinoglory Health yet.
Shandong Sinoglory Health stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shandong Sinoglory Health
Shandong Sinoglory Health Food Co., Ltd., together with its subsidiaries, produces and sells soybean protein series products under the SINOGLORY brand in China and internationally. The company offers soy protein powder drinks, soybean oil, soy dietary fiber products, soy protein isolates and concentrates, textured soy protein products, and low-temperature edible soybean meals for meat applications, vegetarian diets, power drinks and sports nutrition, RTD beverages, and prote…
Full company profileShandong Sinoglory Health financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shandong Sinoglory Health annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 969M | 1.23B | 1.61B | 1.69B | 1.49B | 1.39B | 1.74B |
| Gross Profit | 137M | 162M | 212M | 214M | 185M | 182M | 202M |
| Operating Income | 104M | 112M | 157M | 156M | 132M | 126M | 140M |
| EBITDA | - | - | 185M | 184M | 176M | 196M | 140M |
| Net Income | 74.1M | 79.1M | 114M | 110M | 109M | 94.7M | 99.5M |
| EPS | 0.60 | 0.64 | 0.70 | 0.67 | 0.66 | 0.58 | 0.60 |
| Balance Sheet | |||||||
| Total Assets | 631M | 806M | 1.18B | 1.28B | 1.43B | 1.37B | 1.35B |
| Total Liabilities | 242M | 338M | 218M | 256M | 357M | 270M | 235M |
| Shareholders' Equity | 389M | 468M | 966M | 1.03B | 1.08B | 1.11B | 1.11B |
| Cash & Short-term Investments | 116M | 134M | 437M | 306M | 147M | 94.0M | 153M |
| Cash Flow | |||||||
| Operating Cash Flow | 110M | 43.3M | 109M | 37.3M | 314M | 79.4M | - |
| Capital Expenditure | 71.1M | 33.7M | 45.3M | 155M | 400M | 54.7M | 36.7M |
| Free Cash Flow | 38.6M | 9.64M | 63.9M | -117M | -85.7M | 24.6M | 158M |
| Ratios | |||||||
| ROE | 19.1% | 16.9% | 11.8% | 10.7% | 10.1% | 8.6% | 8.9% |
| ROA | 11.8% | 9.8% | 9.7% | 8.6% | 7.6% | 6.9% | 7.4% |
| Net Profit Margin | 7.6% | 6.4% | 7.1% | 6.5% | 7.3% | 6.8% | 5.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Shandong Sinoglory Health dividends
- Dividend yield
- 3.48%
- Forward dividend
- 0.40 CNY
- Payout ratio
- 69.7%
- Ex-dividend date
- Sep 4, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 66.0M | 0.40 | 69.7% |
| 2024 | CNY 66.4M | 0.40 | 60.9% |
| 2023 | CNY 50.9M | 0.31 | 46.2% |
| 2022 | CNY 3.18M | 0.02 | 2.8% |
| 2021 | CNY 3.92M | 0.03 | 5.0% |
| 2020 | CNY 2.92M | 0.02 | 3.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Shandong Sinoglory Health
- Insiders 54.53%
- Institutions 1.92%
- Public & others 43.56%
- Shares outstanding 165M
- Free float 122M
Shandong Sinoglory Health company profile
- Company name
- Shandong Sinoglory Health
- Ticker
- 603182.SHG
- ISIN
- CNE100005PD6
- Exchange
- Shanghai Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 857
- Fiscal year end
- December
- Address
- No. 19 Hongtu Street, Liaocheng, China, 252400
- Phone
- 86 63 5290 9003
- Website
- sinoglorygroup.com
About Shandong Sinoglory Health
Shandong Sinoglory Health Food Co., Ltd., together with its subsidiaries, produces and sells soybean protein series products under the SINOGLORY brand in China and internationally. The company offers soy protein powder drinks, soybean oil, soy dietary fiber products, soy protein isolates and concentrates, textured soy protein products, and low-temperature edible soybean meals for meat applications, vegetarian diets, power drinks and sports nutrition, RTD beverages, and protein bars. It also engages in foreign trade; import and export of goods and technology; sale of coal; and electricity and heat production and supply activities. The company was formerly known as Shandong Ahua Health Products Co., Ltd. and changed its name to Shandong Sinoglory Health Food Co., Ltd in April 2009. Shandong Sinoglory Health Food Co., Ltd. was incorporated in 2000 and is headquartered in Liaocheng, China.
Shandong Sinoglory Health management
7- Mr. Guangqing LiGM & Vice Chairman of the Board of Director · born 1967
- Mr. Naiyu LiHead of Accounting, Accounting Supervisor & CFO · born 1980
- Mr. Feng TianDeputy GM, Board Secretary & Director · born 1974
- Mr. Lianfeng CaoDeputy General Manager · born 1971
- Mr. Zhiguo AnDeputy General Manager · born 1976
- Mr. Jijun LiDeputy General Manager · born 1975
- Mr. Zhao ZhangDeputy GM & Director of the Research Institute · born 1978